Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Adium Pharma is a leading pharmaceutical company in Latin America with over 40 years of experience. It develops, produces, and commercializes innovative treatments across primary care and specialty/oncology areas. The company has strong partnerships with global pharma/biotech firms to bring advanced therapies to the region. Notably, it partnered with Y-mAbs Therapeutics to launch DANYELZA® for high-risk neuroblastoma in Brazil. Its broad portfolio covers multiple therapeutic areas aimed at improving patient quality of life throughout Latin America.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Adium Pharma.